HighQC™ Human iPSC Line (Episomal, PBMC)
1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
Human iPSC Line (Episomal, PBMC) was derived from human peripheral blood mononuclear cells (PBMCs) by ectopic expression of OCT4, SOX2, KLF4, and L-MYC genes using episomal plasmids.
Species | Human |
Cat.No | ABC-SC001X |
Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Product Category | Primary Cells |
Size/Quantity | 1 vial |
Cell Type | Induced Pluripotent Stem Cell |
Shipping Info | Dry Ice |
Growth Conditions | 37 ℃, 5% CO2 |
Disease | Normal |
Biosafety Level | 1 |
Storage | Liquid Nitrogen |
Product Type | Human iPSCs |
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
For research use only
These are induced pluripotent stem cells generated from peripheral blood mononuclear cells (PBMCs) using episomal vectors. They can differentiate into any cell type, making them valuable for research and regenerative medicine.
They are created by reprogramming PBMCs with episomal vectors, which introduce pluripotency genes without integrating into the genome. This method ensures the production of safer and more stable iPSCs.
They are used in disease modeling, drug screening, and regenerative medicine. They enable the study of genetic diseases and the development of personalized therapies.
Key characteristics include pluripotency marker expression (OCT4, SOX2), ability to differentiate into all three germ layers, and colony morphology resembling embryonic stem cells.
Challenges include maintaining pluripotency, preventing spontaneous differentiation, ensuring genetic stability, and optimizing reprogramming efficiency.